Open-label Extension Study in Paediatric Patients Who Have Completed the MEX-NM-301 Study.

NCT04622553 · clinicaltrials.gov ↗

NA

Phase

ACTIVE_NOT_RECRUITING

Status

14

Enrollment

INDUSTRY

Sponsor class

Conditions

Myotonic Disorders

Interventions

DRUG: Mexiletine

Sponsor

Lupin Ltd.